GOLIM4 and neoplasm: Notably, a group interested in Ca2+ signaling during tumor growth has recently highlighted the importance of GPP130 in cell cycle progression and showed that the knockdown of GPP130 severely impacts cell proliferation in head-and-neck cancer cells [25].